New RAF kinase inhibitors in cancer therapyMARTIN-LIBERAL, Juan; LARKIN, James.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 9, pp 1235-1245, issn 1465-6566, 11 p.Article

Rapid nationwide congestion monitoring : The urban congestion reporting programJUNG, Soojung; WUNDERLICH, Karl; LARKIN, James et al.International IEEE conference on intelligent transportation systems. 2004, pp 286-290, isbn 0-7803-8500-4, 1Vol, 5 p.Conference Paper

Recent advances in SALDI-MS techniques and their chemical and bioanalytical applications : Advnaces in Analytical Mass SpectrometryLAW, K. P; LARKIN, James R.Analytical & bioanalytical chemistry (Print). 2011, Vol 399, Num 8, pp 2597-2622, issn 1618-2642, 26 p.Article

Probing the dust obscuration in seyfert galaxies using infrared spectroscopy. II. Implication for the unification of seyfert galaxiesRHEE, Joseph H; LARKIN, James E.The Astrophysical journal. 2005, Vol 620, Num 1, pp 151-164, issn 0004-637X, 14 p., 1Article

Prospects for MEK inhibitors for treating cancerMARTIN-LIBERAL, Juan; LAGARES-TENA, Laura; LARKIN, James et al.Expert opinion on drug safety. 2014, Vol 13, Num 4, pp 483-495, issn 1474-0338, 13 p.Article

The first spatially resolved MID-infrared spectra of NGC 1068 obtained at diffraction-limited resolution with the keck i telescope long wavelength spectrometerRHEE, Joseph H; LARKIN, James E.The Astrophysical journal. 2006, Vol 640, Num 2, pp 625-638, issn 0004-637X, 14 p., 1Article

Comparison of mobility impacts on urban commuting : Broadcast advisories versus advanced traveler information servicesVASUDEVAN, Meenakshy; WUNDERLICH, Karl; LARKIN, James et al.Transportation research record. 2005, Num 1910, pp 38-45, issn 0361-1981, 8 p.Article

Mice are unsuitable for modelling ABO discordance despite strain-specific A cross-reactive natural IgMLARKIN, James M. G; PORTER, Colin D.British journal of haematology. 2005, Vol 130, Num 2, pp 310-317, issn 0007-1048, 8 p.Article

Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysisLARKIN, James; PAINE, Abby; TUMUR, Indra et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 1, pp 27-39, issn 1465-6566, 13 p.Article

Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced MalignanciesKARAPANAGIOTOU, Eleni M; ROULSTONE, Victoria; COFFEY, Matt et al.Clinical cancer research (Print). 2012, Vol 18, Num 7, pp 2080-2089, issn 1078-0432, 10 p.Article

DETECTION AND CHARACTERIZATION OF EXOPLANETS AND DISKS USING PROJECTIONS ON KARHUNEN-LOEVE EIGENIMAGESSOUMMER, Rémi; PUEYO, Laurent; LARKIN, James et al.The Astrophysical journal. 2012, Vol 755, Num 2, issn 0004-637X, L28.1-L28.5, 2Article

Kinase inhibitors in the treatment of renal cell carcinomaLARKIN, James M. G; EISEN, Tim.Critical reviews in oncology/hematology. 2006, Vol 60, Num 3, pp 216-226, issn 1040-8428, 11 p.Article

Adaptive optics for direct detection of extrasolar planets : the Gemini Planet Imager : Optical techniques for direct imaging of exoplanetsMACINTOSH, Bruce; GRAHAM, James; ERIKSON, Darren et al.Comptes rendus. Physique. 2007, Vol 8, Num 3-4, pp 365-373, issn 1631-0705, 9 p.Article

Axitinib for the Treatment of Metastatic Renal Cell Carcinoma: Recommendations for Therapy Management to Optimize OutcomesLARKIN, James; FISHMAN, Mayer; WOOD, Laura et al.American journal of clinical oncology. 2014, Vol 37, Num 4, pp 397-403, issn 0277-3732, 7 p.Article

Phase I Expansion and Pharmacodynamic Study of the Oral MEK Inhibitor RO4987655 (CH4987655) in Selected Patients with Advanced Cancer with RAS-RAF MutationsZIMMER, Lisa; BARLESI, Fabrice; PACEY, Simon et al.Clinical cancer research (Print). 2014, Vol 20, Num 16, pp 4251-4261, issn 1078-0432, 11 p.Article

Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma BiomarkersGULATI, Sakshi; MARTINEZ, Pierre; BATES, Paul A et al.European urology. 2014, Vol 66, Num 5, pp 936-948, issn 0302-2838, 13 p.Article

Combined Vemurafenib and Cobimetinib in BRAF-Mutated MelanomaLARKIN, James; ASCIERTO, Paolo A; DE LA CRUZ-MERINO, Luis et al.The New England journal of medicine. 2014, Vol 371, Num 20, pp 1867-1876, issn 0028-4793, 10 p.Article

High-Contrast Imaging with Keck Adaptive Optics and OSIRISMCELWAIN, Michael; LARKIN, James; METCHEV, Stanimir et al.Proceedings of SPIE, the International Society for Optical Engineering. 2008, Vol 7015, pp 70151A.1-70151A.12, issn 0277-786X, isbn 978-0-8194-7225-0, 3Vol, 3Conference Paper

The Gemini Planet Imager : from science to design to constructionMACINTOSH, Bruce A; GRAHAM, James R; KENT WALLACE, J et al.Proceedings of SPIE, the International Society for Optical Engineering. 2008, Vol 7015, pp 701518.1-701518.13, issn 0277-786X, isbn 978-0-8194-7225-0, 3Vol, 3Conference Paper

Potential of advanced traveler information system to reduce travel disutility: Assessment in Washington, D.C., RegionSHAH, Vaishali P; WUNDERLICH, Karl; TOPPEN, Alan et al.Transportation research record. 2003, Num 1826, pp 7-15, issn 0361-1981, 9 p.Article

An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapyGRÜNWALD, Viktor; KARAKIEWICZ, Pierre I; BLANK, Christian U et al.European journal of cancer (1990). 2012, Vol 48, Num 3, pp 324-332, issn 0959-8049, 9 p.Article

Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic targetGERLINGER, Marco; SANTOS, Claudio R; DYKEMA, Karl et al.Journal of pathology (Print). 2012, Vol 227, Num 2, pp 146-156, issn 0022-3417, 11 p.Article

Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced MelanomaKIRKWOOD, John M; BASTHOLT, Lars; DUMMER, Reinhard et al.Clinical cancer research (Print). 2012, Vol 18, Num 2, pp 555-567, issn 1078-0432, 13 p.Article

Time management impacts of pretrip advanced traveler information systems. Findings from a Washington, D.C., case studySHAH, Vaishali P; WUNDERLICH, Karl; LARKIN, James et al.Transportation research record. 2001, Num 1774, pp 36-43, issn 0361-1981Conference Paper

A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)MOLINA, Ana M; HUTSON, Thomas E; LARKIN, James et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 1, pp 181-189, issn 0344-5704, 9 p.Article